Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
NEOMYCIN SULFATE BACITRACIN ZINC CYSTEINE THREONINE AMINOACETIC ACID
GlaxoSmithKline (Ireland) Limited
NEOMYCIN SULFATE BACITRACIN ZINC CYSTEINE THREONINE AMINOACETIC ACID
Cutaneous Powder
Product subject to prescription which may not be renewed (A)
Withdrawn
2010-12-01
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cicatrin Cutaneous Powder. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of powder contains: Neomycin Sulphate 3,300 units Bacitracin Zinc 250 units Glycine 10 mg L (+) Cysteine 2 mg DL-Threonine 1 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cutaneous powder. A cream to white free-flowing powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cicatrin Powder is broad-spectrum bactericidal preparations active against pathogens commonly found in infections of the skin. They are indicated in the prevention or treatment of superficial skin infection. These include:- Prophylaxis in minor burns, cuts, scratches and abrasions and following the suturing of lacerations. Treatment of superficial infected ulcers, cuts, scratches, and abrasions, superficial skin infections following surgical procedures, minor burns, impetigo and secondarily infected skin conditions. The use of Cicatrin Powder does not exclude concomitant systemic therapy with other antibiotics where appropriate. (See _Special Warnings and Special Precautions for Use_). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION (Prophylaxis and treatment). _Administration and dosage in adults:_ Before use, the area for application should be cleaned gently. Debris such as pus or crusts should be removed from the affected area. A light dusting of powder should be applied once to four times daily, depending on the clinical condition. Treatment should not be continued for more than 7 days without medical supervision (see _Special Warnings and Special_ _Precautions for Use_). IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 29/10/2008_ _CRN 2057731_ _page number: 1_ Pročitajte cijeli dokument